期刊文献+

非酒精性脂肪性肝病患者血清肝纤维化指标与肝内脂肪含量的相关性研究 被引量:5

Correlation between serum fibrosis markers and intrahepatic fat content in patients with nonalcoholic fatty liver disease
原文传递
导出
摘要 目的探讨非酒精性脂肪性肝病(NAFLD)患者肝纤维化指标与T1WI同/反相位测定肝内脂肪含量的关系。方法选取2017年6~8月非酒精性脂肪性肝病者120例,根据肝纤维化评分(NFS)将患者分为NFS<-1.455亚组(n=35, A组),-1.455≤NFS≤0.676亚组(n=41, B组)及NFS>0.676亚组(n=44, C组)。选择同期体检的年龄、性别、地域相匹配的健康人群50例为对照组,使用SPSS 19.0软件包对数据进行统计分析,肝纤维化指标和肝脏脂肪相对含量用(x^-±s)表示,两两比较采用t检验,多组间比较采用方差分析及Spearman相关分析。P<0.05表示差异有统计学意义。结果 C组随着血清肝纤维化指标CK18、 YKL40、 APRI、 GPRI的升高,肝内脂肪含量减低,呈负相关关系(r=-0.850、-0.584、-0.784、-0.684,P<0.05),A组及B组未发现相关关系(P>0.05)。结论非酒精性脂肪性肝炎有肝纤维化趋势,肝内脂肪含量与肝纤维化的进展密切相关。 Objective To investigate the relationship between the liver fibrosis indexes and liver fat content quantitatively detected by in-phase opposed-phase T1 WI sequences in patients with nonalcoholic fatty liver disease(NAFLD). Methods 120 patients with NAFLD from June to August 2017 were selected. According to the NAFLD fibrosis score(NFS), the patients were divided into NFS<-1.455 subgroup(n=35, group A),-1.455≤NFS≤0.676 subgroup(n=41, group B) and NFS>0.676 subgroup(n=44, group C). A total of 50 healthy subjects with matching age, gender and region were selected as the control group. Serum CK18 and YKL40 levels were detected by ELISA, and liver fat content was detected by in-phase opposed-phase T1 WI sequences. SPSS 19.0 statistical software was used for data analysis. Liver fibrosis indexes and liver fat relative content were showed as (x^-±s), compared with independent t test. Multiple date sets were compared with Variance and Spearman correlation analysis, P<0.05 indicated the difference was statistically significant. Results The values of CK18, YKL40, APRI and GPRI were increased significantly in C group patients, and negative correlation was found(r=-0.850,-0.584,-0.784 and-0.684, P<0.05). The relevance of values of CK18, YKL40, APRI and GPRI and liver fat content in group A and B was not found(P>0.05). Conclusion Liver fibrosis trend was found in nonalcoholic steatohepatitis patients,and the liver fat content is closely related to the progression of liver fibrosis.
作者 付丽坤 盛丽娜 邹春燕 李京龙 谢长顺 南月敏 李莉 Fu Likun;Sheng Lina;Zou Chunyan;Li Jinglong;Xie Changshun;Nan Yuemin;Li Li(Department of Gastroenterology,the First Hospital of Qinhuangdao,Qinhuangdao 066000,China)
出处 《中华普外科手术学杂志(电子版)》 2019年第4期385-387,共3页 Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)
基金 秦皇岛市科学技术局科研项目(201703A044) 中国肝炎防治基金会天晴课题(TQGB20170122)~~
关键词 脂肪肝 肝炎 肝硬化 T1WI同/反相位 Fatty liver Hepatitis Liver cirrhosis In-phase opposed-phase T1WI sequences
  • 相关文献

参考文献7

二级参考文献40

  • 1张华捷,庄辉,刘学恩.脂肪肝的流行病学研究进展[J].中华流行病学杂志,2004,25(7):630-632. 被引量:106
  • 2范明霞,田建明,陆建平,金爱国,曾浩.活体^1H磁共振波谱分析在大鼠脂肪肝中应用价值的初步研究[J].中国医学影像技术,2004,20(10):1503-1505. 被引量:23
  • 3南月敏,王蕾,李良霄,付娜.非酒精性脂肪肝动物模型研究进展[J].河北医科大学学报,2007,28(1):67-69. 被引量:22
  • 4Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009; 50:1072-1078 [PMID: 19585618 DOI: 10.1002/hep.23050].
  • 5Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006; 44:27-33 [PMID: 16799979 DOh 10.1002/hep.21223].
  • 6Feldstein AE, Alkhouri N, De Vito R, Alisi A, Lopez R, Nobili V. Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children. Am J Gastroenterol 2013; 108:1526-1531 [PMID: 23752877 DOI: 10.1038/ajg.2013.168].
  • 7Aida Y, Abe H, Tomita Y, Nagano T, Seki N, Sugita T, Itagaki M, Ishiguro H, Sutoh S, Aizawa Y. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease. Int J Clin Exp Med 2014; 7:4191-4198 [PMID: 25550930].
  • 8Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 2014; 147:765-783.e4 [PMID: 25046161 DOI: 10.1053/j.gastro.2014.07.018].
  • 9Bantel H, Ltigering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004; 40:1078-1087 [PMID: 15486927 DOI: 10.1002/hep.20411].
  • 10中华医学会内分泌分会肝病与代谢学组(筹).中华医学会内分泌分会菲酒精性脂肪性肝病与相关代谢紊乱诊疗共识.中华内分泌代谢杂志2010;26:531-533.

共引文献57

同被引文献49

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部